These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

874 related articles for article (PubMed ID: 25810494)

  • 41. Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants.
    Bullen AL; Katz R; Jotwani V; Garimella PS; Lee AK; Estrella MM; Shlipak MG; Ix JH
    Am J Kidney Dis; 2021 Sep; 78(3):361-368.e1. PubMed ID: 33857535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of pericyte metabolic reprogramming restricts the AKI to CKD transition.
    Xu C; Hong Q; Zhuang K; Ren X; Cui S; Dong Z; Wang Q; Bai X; Chen X
    Metabolism; 2023 Aug; 145():155592. PubMed ID: 37230215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic kidney disease progression is mainly associated with non-recovery of acute kidney injury.
    D'hoore E; Neirynck N; Schepers E; Vanholder R; Verbeke F; Van Thielen M; Van Biesen W
    J Nephrol; 2015 Dec; 28(6):709-16. PubMed ID: 25700932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathway from Acute Kidney Injury to Chronic Kidney Disease: Molecules Involved in Renal Fibrosis.
    Niculae A; Gherghina ME; Peride I; Tiglis M; Nechita AM; Checherita IA
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progression after AKI: Understanding Maladaptive Repair Processes to Predict and Identify Therapeutic Treatments.
    Basile DP; Bonventre JV; Mehta R; Nangaku M; Unwin R; Rosner MH; Kellum JA; Ronco C;
    J Am Soc Nephrol; 2016 Mar; 27(3):687-97. PubMed ID: 26519085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vitamin D deficiency contributes to vascular damage in sustained ischemic acute kidney injury.
    de Bragança AC; Volpini RA; Mehrotra P; Andrade L; Basile DP
    Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27369932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of erythropoietin receptor activity on angiogenesis, tubular injury, and fibrosis in acute kidney injury: a "U-shaped" relationship.
    Shi M; Flores B; Li P; Gillings N; McMillan KL; Ye J; Huang LJ; Sidhu SS; Zhong YP; Grompe MT; Streeter PR; Moe OW; Hu MC
    Am J Physiol Renal Physiol; 2018 Apr; 314(4):F501-F516. PubMed ID: 29187371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New mouse model of chronic kidney disease transitioned from ischemic acute kidney injury.
    Wei J; Zhang J; Wang L; Jiang S; Fu L; Buggs J; Liu R
    Am J Physiol Renal Physiol; 2019 Aug; 317(2):F286-F295. PubMed ID: 31116604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent advances in acute kidney injury and its consequences and impact on chronic kidney disease.
    Zuk A; Bonventre JV
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):397-405. PubMed ID: 30925515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endoplasmic reticulum stress is activated in post-ischemic kidneys to promote chronic kidney disease.
    Shu S; Zhu J; Liu Z; Tang C; Cai J; Dong Z
    EBioMedicine; 2018 Nov; 37():269-280. PubMed ID: 30314894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tubular Elabela-APJ axis attenuates ischemia-reperfusion induced acute kidney injury and the following AKI-CKD transition by protecting renal microcirculation.
    Xiong M; Chen H; Fan Y; Jin M; Yang D; Chen Y; Zhang Y; Petersen RB; Su H; Peng A; Wang C; Zheng L; Huang K
    Theranostics; 2023; 13(10):3387-3401. PubMed ID: 37351176
    [No Abstract]   [Full Text] [Related]  

  • 52. AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease.
    Rodríguez-Romo R; Benítez K; Barrera-Chimal J; Pérez-Villalva R; Gómez A; Aguilar-León D; Rangel-Santiago JF; Huerta S; Gamba G; Uribe N; Bobadilla NA
    Kidney Int; 2016 Feb; 89(2):363-73. PubMed ID: 26509589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential.
    Zhang X; Agborbesong E; Li X
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathophysiology of AKI to CKD progression.
    Sato Y; Takahashi M; Yanagita M
    Semin Nephrol; 2020 Mar; 40(2):206-215. PubMed ID: 32303283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The IRE1/JNK signaling pathway regulates inflammation cytokines and production of glomerular extracellular matrix in the acute kidney injury to chronic kidney disease transition.
    Liang Y; Qu L; Liu Z; Liang L; Wang Y; Quan S; Wang Y; Tang L
    Mol Biol Rep; 2022 Aug; 49(8):7709-7718. PubMed ID: 35696049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CSF-1R inhibition attenuates ischemia-induced renal injury and fibrosis by reducing Ly6C
    Deng X; Yang Q; Wang Y; Zhou C; Guo Y; Hu Z; Liao W; Xu G; Zeng R
    Int Immunopharmacol; 2020 Nov; 88():106854. PubMed ID: 32771945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TNF or EGFR inhibition equally block AKI-to-CKD transition: opportunities for etanercept treatment.
    Abdelmageed MM; Kefaloyianni E; Arthanarisami A; Komaru Y; Atkinson JJ; Herrlich A
    Nephrol Dial Transplant; 2023 May; 38(5):1139-1150. PubMed ID: 36269313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis.
    Lan R; Geng H; Polichnowski AJ; Singha PK; Saikumar P; McEwen DG; Griffin KA; Koesters R; Weinberg JM; Bidani AK; Kriz W; Venkatachalam MA
    Am J Physiol Renal Physiol; 2012 May; 302(9):F1210-23. PubMed ID: 22301622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
    Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathophysiology of AKI: injury and normal and abnormal repair.
    Bonventre JV
    Contrib Nephrol; 2010; 165():9-17. PubMed ID: 20427950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.